product1 publisher
Amodei, Altman, Musk and Hassabis all say the latest LLMs are not safe
MIT Technology Review says the four have converged on caution while their labs chase trillion-dollar IPOs. Nobody in the account named a new release date, so nothing in it moves a delivery plan.
Publishers:technologyreview.com
Reality
- Evidence40
- Adoption
- Insufficient
- Hype gap+25
- Incentives75
- Confidence45